NasdaqGS:VTRSPharmaceuticals
Should Viatris’ (VTRS) First Inpefa UAE Launch Shape Investor Views on Its Innovation Strategy?
Viatris Inc. recently launched Inpefa (sotagliflozin) in the United Arab Emirates, its first commercialization of the heart failure treatment in its territories outside the U.S. and Europe, following an exclusive licensing deal with Lexicon Pharmaceuticals for markets beyond those regions.
This marks Viatris’ first international rollout of a dual SGLT1/2 inhibitor for cardiovascular disease, highlighting an effort to broaden its innovative portfolio and expand patient access in key markets...